Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Bimatoprost effectively enhances eyelash growth but may not work for all eyelash loss conditions.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Latanoprost works better for hair growth, and combining it with betamethasone valerate is most effective.

Triamcinolone acetonide effectively treated black hairy tongue.

Combining injections with lotion is more effective for hair regrowth in alopecia areata than using the lotion alone.

Some psychiatric medications can cause reversible hair loss.

Topical valproate can effectively promote hair growth.

Valproic acid can cause weight gain and hair texture changes.

Hypothyroidism can cause hair loss, which is often reversible with treatment.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Some hair loss from medication may reverse after stopping the drug, but treatment options are limited and ongoing research is needed.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Intradermotherapy is a safe and effective short-term treatment for hair loss.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Generalized trichoepitheliomas with alopecia may indicate myasthenia gravis.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.